These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
727 related articles for article (PubMed ID: 23127371)
41. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069 [TBL] [Abstract][Full Text] [Related]
42. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. Martini N; Bains MS; Burt ME; Zakowski MF; McCormack P; Rusch VW; Ginsberg RJ J Thorac Cardiovasc Surg; 1995 Jan; 109(1):120-9. PubMed ID: 7815787 [TBL] [Abstract][Full Text] [Related]
43. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. Maeda R; Yoshida J; Ishii G; Aokage K; Hishida T; Nishimura M; Nishiwaki Y; Nagai K J Thorac Oncol; 2010 Aug; 5(8):1246-50. PubMed ID: 20559152 [TBL] [Abstract][Full Text] [Related]
44. Surgical Outcomes of Non-small Cell Lung Cancer in Patients with a History of Pancreaticobiliary Cancer. Tagawa T; Ito K; Fukuzawa K; Okamoto T; Fujinaga A; Kawasaki T; Masuda T; Iwaki K; Terashi T; Okamoto M; Shiromizu A; Motohiro A; Maehara Y Anticancer Res; 2017 Jun; 37(6):3307-3309. PubMed ID: 28551682 [TBL] [Abstract][Full Text] [Related]
45. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122 [TBL] [Abstract][Full Text] [Related]
46. Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary report. Chiu CH; Chern MS; Wu MH; Hsu WH; Wu YC; Huang MH; Chang SC J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1300-5. PubMed ID: 12830048 [TBL] [Abstract][Full Text] [Related]
47. Assessment of recurrence of non-small cell lung cancer after therapy using CT and Integrated PET/CT. Opoka L; Szołkowska M; Podgajny Z; Kunikowska J; Barańska I; Błasińska-Przerwa K; Jakubowska L; Rudziński P; Bestry I; Roszkowski-Śliż K Pneumonol Alergol Pol; 2013; 81(3):214-20. PubMed ID: 23609428 [TBL] [Abstract][Full Text] [Related]
48. Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer. Casiraghi M; Maisonneuve P; Piperno G; Bellini R; Brambilla D; Petrella F; Marinis F; Spaggiari L Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):233-241. PubMed ID: 28823336 [TBL] [Abstract][Full Text] [Related]
49. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer. Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368 [TBL] [Abstract][Full Text] [Related]
50. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data. Kelsey CR; Higgins KA; Peterson BL; Chino JP; Marks LB; D'Amico TA; Varlotto JM J Thorac Cardiovasc Surg; 2013 Oct; 146(4):768-773.e1. PubMed ID: 23856204 [TBL] [Abstract][Full Text] [Related]
52. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer. Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803 [TBL] [Abstract][Full Text] [Related]
53. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160 [TBL] [Abstract][Full Text] [Related]
54. Predicting recurrence of non-small cell lung cancer based on mean computed tomography value. Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Takata M J Cardiothorac Surg; 2021 May; 16(1):128. PubMed ID: 33980268 [TBL] [Abstract][Full Text] [Related]
55. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer. Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444 [TBL] [Abstract][Full Text] [Related]
56. Characteristics of local recurrence of lung cancer and possibilities for surgical management. Stojiljkovic D; Mandaric D; Miletic N; Stojsic J; Markovic I; Gavrilovic D; Pupic G; Stojiljkovic T; Lukac B; Dzodic R J BUON; 2013; 18(1):169-75. PubMed ID: 23613403 [TBL] [Abstract][Full Text] [Related]
57. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study. McMurry TL; Stukenborg GJ; Kessler LG; Colditz GA; Wong ML; Francescatti AB; Jones DR; Schumacher JR; Greenberg CC; Chang GJ; Winchester DP; McKellar DP; Kozower BD Ann Surg; 2018 Oct; 268(4):632-639. PubMed ID: 30004919 [TBL] [Abstract][Full Text] [Related]
58. Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type. Choi YS; Shim YM; Kim K; Kim J J Korean Med Sci; 2004 Oct; 19(5):674-6. PubMed ID: 15483342 [TBL] [Abstract][Full Text] [Related]
59. Prognostic value of 18-FDG uptake in early stage NSCLC. Chen JC; Huang TW; Cheng YL; Chang H; Tzao C; Huang WS; Lee SC Thorac Cardiovasc Surg; 2009 Oct; 57(7):413-6. PubMed ID: 19795329 [TBL] [Abstract][Full Text] [Related]
60. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer? Kozower BD; Meyers BF; Reed CE; Jones DR; Decker PA; Putnam JB Ann Thorac Surg; 2008 Apr; 85(4):1166-9; discussion 1169-70. PubMed ID: 18355490 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]